Cover Image
市場調查報告書

醫療用生物感應器的全球市場:2017年∼2021年

Global Medical Biosensors Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 240774
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
醫療用生物感應器的全球市場:2017年∼2021年 Global Medical Biosensors Market 2017-2021
出版日期: 2017年05月17日 內容資訊: 英文 70 Pages
簡介

全球醫療用生物感應器市場,預計從2017年到2021年之間,以8.19%的年複合成長率 (CAGR) 擴大。

本報告提供全球醫療用生物感應器市場概要、結構和市場趨勢,各地區的詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查、考察。

第1章 摘要整理

第2章 本報告的調查範圍

第3章 調查手法

第4章 簡介

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 各用途的市場分類

  • 全球醫療用生物感應器市場:各用途
  • 血糖值檢驗
  • 膽固醇值檢驗
  • 生物標記
  • 其他

第7章 各終端用戶的市場分類

  • 全球醫療用生物感應器市場:各終端用戶
  • POCT
  • 家庭
  • 研究機關

第8章 地理區分

  • 地理區分
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區

第9章 決策架構

第10章 市場成長因素與課題

  • 市場成長因素
  • 市場課題

第11章 市場趨勢

第12章 業者情勢

  • 競爭模式

第13章 主要供應商分析

  • Abbott Laboratories
  • Bayer
  • LifeScan
  • F. Hoffmann-La Roche
  • 其他卓越供應商

第14章 簡稱清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR13098

About Biosensors

A biosensor is used to identify an analyte that combines a biological component with a physicochemical detector component. An analytical device that is used to analyze a sample for the presence of a specific compound or analyte is known as a sensor. It utilizes biological materials to specifically interact with an analyte.

Technavio's analysts forecast the global biosensors market to grow at a CAGR of 8.19% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global biosensors market for 2017-2021. To calculate the market size, the report considers the sales of medical biosensors.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Biosensors Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Bayer
  • LifeScan
  • F. Hoffmann-La Roche

Other Prominent Vendors

  • ACON
  • Biotest Medical
  • Biosensors International Group
  • CONTEC MEDICAL SYSTEMS
  • i-SENS
  • Optiscan
  • Nipro Diagnostics
  • TaiDoc
  • URIT Medical

Market driver

  • Shift toward home testing
  • For a full, detailed list, view our report

Market challenge

  • High cost of devices
  • For a full, detailed list, view our report

Market trend

  • Increased availability of disposable biosensors
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by application

  • Global medical biosensors market by application
  • Global medical biosensors market by blood glucose testing
  • Global medical biosensors market by cholesterol testing
  • Global medical biosensors market by biomarker
  • Global medical biosensors market by others

PART 07: Market segmentation by end-user

  • Global medical biosensors market by end-users
  • Global medical biosensors market by POCT
  • Global medical biosensors market by home diagnostics
  • Global medical biosensors market by research laboratories

PART 08: Geographical segmentation

  • Global medical biosensors market by Geographical Segmentation
  • Medical biosensors market in Americas
  • Medical biosensors market in EMEA
  • Medical biosensors market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Ranking of trends on the scale of 5

PART 12: Vendor landscape

  • Competitive Scenario

PART 13: Key vendor analysis

  • Abbott Laboratories
  • Bayer
  • LifeScan
  • F. Hoffmann-La Roche
  • Other prominent vendors

PART 14: Abbreviations

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Types of medical biosensors
  • Exhibit 02: Applications by key end-users
  • Exhibit 03: Market overview: Global medical biosensors market
  • Exhibit 04: Global medical biosensors market 2016-2021 ($ billion)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Global medical biosensors market by application 2016-2021
  • Exhibit 07: Global medical biosensors market by blood glucose testing 2016-2021 ($ billion)
  • Exhibit 08: Global medical biosensors market by cholesterol testing 2016-2021 ($ billion)
  • Exhibit 09: Global medical biosensors market by biomarker 2016-2021 ($ billion)
  • Exhibit 10: Global medical biosensors market by others 2016-2021 ($ billion)
  • Exhibit 11: Global medical biosensors market by end-users 2016-2021
  • Exhibit 12: Global medical biosensors market by POCT 2016-2021 ($ billion)
  • Exhibit 13: Global medical biosensors market by home diagnostics 2016-2021 ($ billion)
  • Exhibit 14: Global medical biosensors market by research laboratories 2016-2021 ( $ billion)
  • Exhibit 15: Global medical biosensors market by geography 2016-2021
  • Exhibit 16: Medical biosensors market in Americas 2016-2021 ($ billion)
  • Exhibit 17: Medical biosensors market in EMEA 2016-2021 ($ billion)
  • Exhibit 18: Medical biosensors market in APAC 2016-2021 ($ billion)
  • Exhibit 19: Ranking of trends on a scale of 5
  • Exhibit 20: Key news on recent developments of biosensors 2017
  • Exhibit 21: Abbott Laboratories: Strength analysis
  • Exhibit 22: Abbott Laboratories: Strategy assessment
  • Exhibit 23: Abbott Laboratories: Opportunity assessment
  • Exhibit 24: Bayer: Strength analysis
  • Exhibit 25: Bayer: Strategy assessment
  • Exhibit 26: Bayer: Opportunity assessment
  • Exhibit 27: LifeScan: Strength analysis
  • Exhibit 28: LifeScan: Strategy assessment
  • Exhibit 29: LifeScan: Opportunity assessment
  • Exhibit 30: F. Hoffmann-La Roche: Strength analysis
  • Exhibit 31: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 32: F. Hoffmann-La Roche: Opportunity assessment
Back to Top